http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4820700-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_359b45ab51dbd97bd513b984a50c5ef0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0031 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 |
| filingDate | 1987-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1989-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89d0c2540cbe098f6f4122e8bd1d1a9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2fe219f29f320319451a352eec7d4d0 |
| publicationDate | 1989-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4820700-A |
| titleOfInvention | Novel androstane-17β-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions |
| abstract | The invention refers to compounds having anti-inflammatory activity, characterized by the formula <IMAGE> (I) in the form of a stereoisomeric mixture or an epimer of the R or S type regarding the orientation of the substituents in the carbon atom at position 20, in which formula the 1,2 position is saturated or is a double bond, X1 is hydrogen, fluorine, chlorine or bromine, X2 is hydrogen, fluorine, chlorine or bromine, R1 is hydrogen or methyl, R2 is a straight or branched hydrocarbon chain having 1-10 carbon atoms and R3 is hydrogen or a straight or branched chain alkyl group having 1-12 carbon atoms, a lower alkyl group substituted by 1-5 halogen atoms or an unsubstituted or substituted phenyl or benzyl group, provided that when R1 is methyl R2 is a hydrocarbon chain having 2-10 carbon atoms. The invention also refers to a process and intermediates for the preparation of these compounds, a pharmaceutical preparation containing one of the compounds and a method for the treatment of inflammatory conditions. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009286835-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6140308-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010256103-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010256104-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010256105-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8338587-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5908833-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009108118-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8163724-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010261690-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011160167-A1 |
| priorityDate | 1983-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 190.